 | • レポートコード：D0GIR-00970 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥508,080 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥762,120 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,016,160 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ウイルスベクター製造の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウイルスベクター製造の種類別市場規模（アデノウイルスベクター、アデノ随伴ウイルスベクター、レトロウイルスベクター、レンチウイルスベクター、その他）、用途別市場規模（遺伝子治療、ワクチン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Cobra Biologics、Spark Therapeutics、Novasep、Finvector、Sanofi、Merck、Thermo Fisher Scientific、Fujifilm Diosynth Biotechnologies、Oxford BioMedica、Kaneka Corporation (Eurogentec) ・地域別グローバル市場分析 2015年-2020年 ・ウイルスベクター製造の北米市場（アメリカ、カナダ、メキシコ） ・ウイルスベクター製造のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ウイルスベクター製造のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ウイルスベクター製造の南米市場（ブラジル、アルゼンチン） ・ウイルスベクター製造の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アデノウイルスベクター、アデノ随伴ウイルスベクター、レトロウイルスベクター、レンチウイルスベクター、その他 ・用途別分析：遺伝子治療、ワクチン ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Viral Vector Manufacturing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Viral Vector Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Viral Vector Manufacturing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Viral Vector Manufacturing market has been segmented into:
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other
By Application, Viral Vector Manufacturing has been segmented into:
Gene Therapy
Vaccinology
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Vector Manufacturing market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Vector Manufacturing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Vector Manufacturing market.
The report offers in-depth assessment of the growth and other aspects of the Viral Vector Manufacturing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Viral Vector Manufacturing Market Share Analysis
Viral Vector Manufacturing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Vector Manufacturing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Vector Manufacturing sales, revenue and market share for each player covered in this report.
The major players covered in Viral Vector Manufacturing are:
Cobra Biologics
Spark Therapeutics
Novasep
Finvector
Sanofi
Merck
Thermo Fisher Scientific
Fujifilm Diosynth Biotechnologies
Oxford BioMedica
Kaneka Corporation (Eurogentec)
Table of Contents
1 Viral Vector Manufacturing Market Overview
1.1 Product Overview and Scope of Viral Vector Manufacturing
1.2 Classification of Viral Vector Manufacturing by Type
1.2.1 Global Viral Vector Manufacturing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Viral Vector Manufacturing Revenue Market Share by Type in 2019
1.2.3 Adenoviral Vectors
1.2.4 Adeno-associated Viral Vectors
1.2.5 Retroviral Vectors
1.2.6 Lentiviral Vectors
1.2.7 Other
1.3 Global Viral Vector Manufacturing Market by Application
1.3.1 Overview: Global Viral Vector Manufacturing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Global Viral Vector Manufacturing Market by Regions
1.4.1 Global Viral Vector Manufacturing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Viral Vector Manufacturing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Viral Vector Manufacturing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Viral Vector Manufacturing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Vector Manufacturing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Viral Vector Manufacturing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Vector Manufacturing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Cobra Biologics
2.1.1 Cobra Biologics Details
2.1.2 Cobra Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cobra Biologics SWOT Analysis
2.1.4 Cobra Biologics Product and Services
2.1.5 Cobra Biologics Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Spark Therapeutics
2.2.1 Spark Therapeutics Details
2.2.2 Spark Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Spark Therapeutics SWOT Analysis
2.2.4 Spark Therapeutics Product and Services
2.2.5 Spark Therapeutics Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novasep
2.3.1 Novasep Details
2.3.2 Novasep Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novasep SWOT Analysis
2.3.4 Novasep Product and Services
2.3.5 Novasep Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Finvector
2.4.1 Finvector Details
2.4.2 Finvector Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Finvector SWOT Analysis
2.4.4 Finvector Product and Services
2.4.5 Finvector Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Thermo Fisher Scientific SWOT Analysis
2.7.4 Thermo Fisher Scientific Product and Services
2.7.5 Thermo Fisher Scientific Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fujifilm Diosynth Biotechnologies
2.8.1 Fujifilm Diosynth Biotechnologies Details
2.8.2 Fujifilm Diosynth Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fujifilm Diosynth Biotechnologies SWOT Analysis
2.8.4 Fujifilm Diosynth Biotechnologies Product and Services
2.8.5 Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Oxford BioMedica
2.9.1 Oxford BioMedica Details
2.9.2 Oxford BioMedica Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Oxford BioMedica SWOT Analysis
2.9.4 Oxford BioMedica Product and Services
2.9.5 Oxford BioMedica Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Kaneka Corporation (Eurogentec)
2.10.1 Kaneka Corporation (Eurogentec) Details
2.10.2 Kaneka Corporation (Eurogentec) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Kaneka Corporation (Eurogentec) SWOT Analysis
2.10.4 Kaneka Corporation (Eurogentec) Product and Services
2.10.5 Kaneka Corporation (Eurogentec) Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Viral Vector Manufacturing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Vector Manufacturing Players Market Share
3.2.2 Top 10 Viral Vector Manufacturing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Viral Vector Manufacturing Revenue and Market Share by Regions
4.2 North America Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
4.3 Europe Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
4.5 South America Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
5 North America Viral Vector Manufacturing Revenue by Countries
5.1 North America Viral Vector Manufacturing Revenue by Countries (2015-2020)
5.2 USA Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
5.3 Canada Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
5.4 Mexico Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
6 Europe Viral Vector Manufacturing Revenue by Countries
6.1 Europe Viral Vector Manufacturing Revenue by Countries (2015-2020)
6.2 Germany Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
6.3 UK Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
6.4 France Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
6.5 Russia Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
6.6 Italy Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Viral Vector Manufacturing Revenue by Countries
7.1 Asia-Pacific Viral Vector Manufacturing Revenue by Countries (2015-2020)
7.2 China Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
7.3 Japan Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
7.4 Korea Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
7.5 India Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
8 South America Viral Vector Manufacturing Revenue by Countries
8.1 South America Viral Vector Manufacturing Revenue by Countries (2015-2020)
8.2 Brazil Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
8.3 Argentina Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Viral Vector Manufacturing by Countries
9.1 Middle East & Africa Viral Vector Manufacturing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
9.3 UAE Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
9.4 Egypt Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
9.5 South Africa Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Viral Vector Manufacturing Revenue and Market Share by Type (2015-2020)
10.2 Global Viral Vector Manufacturing Market Forecast by Type (2019-2024)
10.3 Adenoviral Vectors Revenue Growth Rate (2015-2025)
10.4 Adeno-associated Viral Vectors Revenue Growth Rate (2015-2025)
10.5 Retroviral Vectors Revenue Growth Rate (2015-2025)
10.6 Lentiviral Vectors Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Viral Vector Manufacturing Market Segment by Application
11.1 Global Viral Vector Manufacturing Revenue Market Share by Application (2015-2020)
11.2 Viral Vector Manufacturing Market Forecast by Application (2019-2024)
11.3 Gene Therapy Revenue Growth (2015-2020)
11.4 Vaccinology Revenue Growth (2015-2020)
12 Global Viral Vector Manufacturing Market Size Forecast (2021-2025)
12.1 Global Viral Vector Manufacturing Market Size Forecast (2021-2025)
12.2 Global Viral Vector Manufacturing Market Forecast by Regions (2021-2025)
12.3 North America Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
12.4 Europe Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
12.6 South America Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Viral Vector Manufacturing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Viral Vector Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Viral Vector Manufacturing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Viral Vector Manufacturing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Cobra Biologics Corporate Information, Location and Competitors
Table 6. Cobra Biologics Viral Vector Manufacturing Major Business
Table 7. Cobra Biologics Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 8. Cobra Biologics SWOT Analysis
Table 9. Cobra Biologics Viral Vector Manufacturing Product and Solutions
Table 10. Cobra Biologics Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Spark Therapeutics Corporate Information, Location and Competitors
Table 12. Spark Therapeutics Viral Vector Manufacturing Major Business
Table 13. Spark Therapeutics Viral Vector Manufacturing Total Revenue (USD Million) (2018-2019)
Table 14. Spark Therapeutics SWOT Analysis
Table 15. Spark Therapeutics Viral Vector Manufacturing Product and Solutions
Table 16. Spark Therapeutics Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novasep Corporate Information, Location and Competitors
Table 18. Novasep Viral Vector Manufacturing Major Business
Table 19. Novasep Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 20. Novasep SWOT Analysis
Table 21. Novasep Viral Vector Manufacturing Product and Solutions
Table 22. Novasep Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Finvector Corporate Information, Location and Competitors
Table 24. Finvector Viral Vector Manufacturing Major Business
Table 25. Finvector Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 26. Finvector SWOT Analysis
Table 27. Finvector Viral Vector Manufacturing Product and Solutions
Table 28. Finvector Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Viral Vector Manufacturing Major Business
Table 31. Sanofi Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Viral Vector Manufacturing Product and Solutions
Table 34. Sanofi Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Corporate Information, Location and Competitors
Table 36. Merck Viral Vector Manufacturing Major Business
Table 37. Merck Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 38. Merck SWOT Analysis
Table 39. Merck Viral Vector Manufacturing Product and Solutions
Table 40. Merck Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 42. Thermo Fisher Scientific Viral Vector Manufacturing Major Business
Table 43. Thermo Fisher Scientific Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 44. Thermo Fisher Scientific SWOT Analysis
Table 45. Thermo Fisher Scientific Viral Vector Manufacturing Product and Solutions
Table 46. Thermo Fisher Scientific Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Fujifilm Diosynth Biotechnologies Corporate Information, Location and Competitors
Table 48. Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Major Business
Table 49. Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 50. Fujifilm Diosynth Biotechnologies SWOT Analysis
Table 51. Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Product and Solutions
Table 52. Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Oxford BioMedica Corporate Information, Location and Competitors
Table 54. Oxford BioMedica Viral Vector Manufacturing Major Business
Table 55. Oxford BioMedica Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 56. Oxford BioMedica SWOT Analysis
Table 57. Oxford BioMedica Viral Vector Manufacturing Product and Solutions
Table 58. Oxford BioMedica Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Kaneka Corporation (Eurogentec) Corporate Information, Location and Competitors
Table 60. Kaneka Corporation (Eurogentec) Viral Vector Manufacturing Major Business
Table 61. Kaneka Corporation (Eurogentec) Viral Vector Manufacturing Total Revenue (USD Million) (2017-2018)
Table 62. Kaneka Corporation (Eurogentec) SWOT Analysis
Table 63. Kaneka Corporation (Eurogentec) Viral Vector Manufacturing Product and Solutions
Table 64. Kaneka Corporation (Eurogentec) Viral Vector Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Viral Vector Manufacturing Revenue (Million USD) by Players (2015-2020)
Table 66. Global Viral Vector Manufacturing Revenue Share by Players (2015-2020)
Table 67. Global Viral Vector Manufacturing Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Viral Vector Manufacturing Revenue Market Share by Regions (2015-2020)
Table 69. North America Viral Vector Manufacturing Revenue by Countries (2015-2020)
Table 70. North America Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Table 71. Europe Viral Vector Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Viral Vector Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Viral Vector Manufacturing Revenue by Countries (2015-2020)
Table 74. South America Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Viral Vector Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Table 77. Global Viral Vector Manufacturing Revenue (Million USD) by Type (2015-2020)
Table 78. Global Viral Vector Manufacturing Revenue Share by Type (2015-2020)
Table 79. Global Viral Vector Manufacturing Revenue Forecast by Type (2021-2025)
Table 80. Global Viral Vector Manufacturing Revenue by Application (2015-2020)
Table 81. Global Viral Vector Manufacturing Revenue Share by Application (2015-2020)
Table 82. Global Viral Vector Manufacturing Revenue Forecast by Application (2021-2025)
Table 83. Global Viral Vector Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Viral Vector Manufacturing Picture
Figure 2. Global Viral Vector Manufacturing Revenue Market Share by Type in 2019
Figure 3. Adenoviral Vectors Picture
Figure 4. Adeno-associated Viral Vectors Picture
Figure 5. Retroviral Vectors Picture
Figure 6. Lentiviral Vectors Picture
Figure 7. Other Picture
Figure 8. Viral Vector Manufacturing Revenue Market Share by Application in 2019
Figure 9. Gene Therapy Picture
Figure 10. Vaccinology Picture
Figure 11. Global Viral Vector Manufacturing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Viral Vector Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Viral Vector Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Viral Vector Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Viral Vector Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Viral Vector Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Viral Vector Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Viral Vector Manufacturing Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Viral Vector Manufacturing Revenue Market Share in 2019
Figure 20. Global Top 10 Players Viral Vector Manufacturing Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Viral Vector Manufacturing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Viral Vector Manufacturing Revenue Market Share by Regions (2015-2020)
Figure 24. Global Viral Vector Manufacturing Revenue Market Share by Regions in 2018
Figure 25. North America Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 26. Europe Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 28. South America Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 30. North America Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 31. North America Viral Vector Manufacturing Revenue Market Share by Countries in 2019
Figure 32. USA Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 33. Canada Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 35. Europe Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Viral Vector Manufacturing Revenue Market Share by Countries in 2019
Figure 37. Germany Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 38. UK Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 39. France Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 40. Russia Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 41. Italy Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Viral Vector Manufacturing Revenue Market Share by Countries in 2019
Figure 44. China Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 45. Japan Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 46. Korea Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 47. India Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 49. South America Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 50. South America Viral Vector Manufacturing Revenue Market Share by Countries in 2019
Figure 51. Brazil Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Viral Vector Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Viral Vector Manufacturing Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 56. UAE Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Viral Vector Manufacturing Revenue and Growth Rate (2015-2020)
Figure 59. Global Viral Vector Manufacturing Revenue Share by Type (2015-2020)
Figure 60. Global Viral Vector Manufacturing Revenue Share by Type in 2019
Figure 61. Global Viral Vector Manufacturing Market Share Forecast by Type (2021-2025)
Figure 62. Global Adenoviral Vectors Revenue Growth Rate (2015-2020)
Figure 63. Global Adeno-associated Viral Vectors Revenue Growth Rate (2015-2020)
Figure 64. Global Retroviral Vectors Revenue Growth Rate (2015-2020)
Figure 65. Global Lentiviral Vectors Revenue Growth Rate (2015-2020)
Figure 66. Global Other Revenue Growth Rate (2015-2020)
Figure 67. Global Viral Vector Manufacturing Revenue Share by Application (2015-2020)
Figure 68. Global Viral Vector Manufacturing Revenue Share by Application in 2019
Figure 69. Global Viral Vector Manufacturing Market Share Forecast by Application (2021-2025)
Figure 70. Global Gene Therapy Revenue Growth Rate (2015-2020)
Figure 71. Global Vaccinology Revenue Growth Rate (2015-2020)
Figure 72. Global Viral Vector Manufacturing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Viral Vector Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Viral Vector Manufacturing Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
Figure 76. Europe Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
Figure 78. South America Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Viral Vector Manufacturing Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
ウイルス性結膜炎薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Viral Conjunctivitis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Viral Conjunctivit…- ウイルスクリアランスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Viral Clearance market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 338.5 million by 2025, from USD 223.8 million in 2019. The Viral Clearance marke…
- ウイルス分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Viral Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10750 million by 2025, from USD 8231.6 million in 2019. The Viral Mol…
- ウイルス輸送媒体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Viral Transport Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 節足動物媒介ウイルス感染検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Arthropod-borne Viral Infections Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …